HeLa cells stably expressing WT or mutant PMP22-GFP were treated with control or
Hrd1 siRNA (Hrd1 #1) for 3 days. Immunoblots of cell lysates were probed with anti-GFP, anti-Hrd1, anti-gp78, and anti-α-actin antibodies. Note that Hrd1 #1 also reduced the protein level of gp78, suggesting that this siRNA has an off-target effect on gp78 to some extent. HeLa cells stably expressing PMP22(G150D)-GFP were treated with control or siRNA against Rer1, calnexin, or both for 3 days. Then, fixed cells were immunostained using an antibody against Lamp1 (a late endosome/lysosome marker) and observed using 3 confocal laser scanning microscopy. Scale bars, 10 μm. Original gel images of Figure 6 
